These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 34837962)

  • 1. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
    Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
    Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
    Zhang Q; Cheng S; Cao L; Yang J; Wang Y; Chen Y
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32077915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
    Wang J; Luo Z; Yao T; Li W; Pu J
    J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway.
    Cheng X; Chen M; Liu Z
    Am J Med Sci; 2020 Jun; 359(6):365-371. PubMed ID: 32498943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways.
    Li Y; Xiong H
    BMC Cancer; 2022 Mar; 22(1):298. PubMed ID: 35313850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX; Liao R; Pan L; Du CY
    Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.
    Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W
    J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
    Zhang C; Wang X; Fang D; Xu P; Mo X; Hu C; Abdelatty A; Wang M; Xu H; Sun Q; Zhou G; She J; Xia J; Hui KM; Xia H
    Theranostics; 2021; 11(5):2108-2122. PubMed ID: 33500714
    [No Abstract]   [Full Text] [Related]  

  • 10. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 11. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells.
    Sun WJ; Huang H; He B; Hu DH; Li PH; Yu YJ; Zhou XH; Lv Z; Zhou L; Hu TY; Yao ZC; Lu MD; Shen X; Zheng ZQ
    Biochem Pharmacol; 2017 Mar; 127():90-100. PubMed ID: 28012958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma.
    Zhang C; Liu J; Han Z; Cui X; Peng D; Xing Y
    Int J Clin Oncol; 2020 Jun; 25(6):1145-1154. PubMed ID: 32240440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
    Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-370 functions as a tumor suppressor in hepatocellular carcinoma via inhibition of the MAPK/JNK signaling pathway by targeting BEX2.
    Wang X; Zhu W; Xu C; Wang F; Zhu X; Sun Y; Guo Y; Fu X; Zhang Y; Zang Y
    J Hum Genet; 2019 Dec; 64(12):1203-1217. PubMed ID: 31530937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction.
    Xu Y; Zheng Y; Liu H; Li T
    Int J Oncol; 2017 Sep; 51(3):791-800. PubMed ID: 28677801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of proliferation and metastasis of hepatocellular carcinoma by LncRNA00673 based on the targeted-regulation of notch signaling pathway.
    Chen H; Liu JZ; Hu GJ; Shi LL; Lan T
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3412-3420. PubMed ID: 28829500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
    Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin Y Modulates the Proliferation, Invasion, and Metastasis of Hepatocellular Carcinoma Cells.
    Shi K; Ru Q; Zhang C; Huang J
    Med Sci Monit; 2018 Mar; 24():1642-1653. PubMed ID: 29557391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L; Zheng J; Chen P; Liu Q; Yuan Y
    Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.